T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Cirrus Logic
CRUS
$6.08B
| $33.2M | ﹤0.01% |
358,348
+452
| +0.1% | +$39K |
|
827
Workiva
WK
$4.01B
| $33.2M | ﹤0.01% |
390,939
-11,080
| -3% | -$998K |
|
828
Patrick Industries
PATK
$2.78B
| $33.1M | ﹤0.01% |
415,305
+39,583
| +11% | +$2.84M |
|
829
DTE Energy
DTE
$29B
| $33M | ﹤0.01% |
293,958
+3,672
| +1% | +$396K |
|
830
First Industrial Realty Trust
FR
$8.4B
| $32.8M | ﹤0.01% |
624,638
+1,304
| +0.2% | +$68.9K |
|
831
SL Green Realty
SLG
$4.08B
| $32.8M | ﹤0.01% |
594,309
-46,814
| -7% | -$2.22M |
|
832
Grupo Aeroportuario del Sureste
ASR
$8.01B
| $32.8M | ﹤0.01% |
102,775
-11,381
| -10% | -$3.35M |
|
833
Denali Therapeutics
DNLI
$3.97B
| $32.7M | ﹤0.01% |
1,594,333
-979,988
| -38% | -$18.4M |
|
834
Grand Canyon Education
LOPE
$3.79B
| $32.7M | ﹤0.01% |
240,138
-151,721
| -39% | -$19.8M |
|
835
Praxis Precision Medicines
PRAX
$10.3B
| $32.7M | ﹤0.01% |
+535,999
| New | +$24M |
|
836
Addus HomeCare
ADUS
$2.2B
| $32.7M | ﹤0.01% |
316,442
-61,689
| -16% | -$5.76M |
|
837
Akamai
AKAM
$18B
| $32.7M | ﹤0.01% |
300,519
-10,921
| -4% | -$1.26M |
|
838
Nasdaq
NDAQ
$54.6B
| $32.6M | ﹤0.01% |
517,000
+57,900
| +13% | +$3.35M |
|
839
MarketAxess Holdings
MKTX
$5.72B
| $32.5M | ﹤0.01% |
148,356
-720,475
| -83% | -$170M |
|
840
Iridium Communications
IRDM
$5.27B
| $32.5M | ﹤0.01% |
1,241,075
-8,964
| -0.7% | -$292K |
|
841
Nurix Therapeutics
NRIX
$2.82B
| $32.3M | ﹤0.01% |
2,196,169
-193,797
| -8% | -$2.08M |
|
842
Bloomin' Brands
BLMN
$924M
| $32.3M | ﹤0.01% |
1,125,008
+41,128
| +4% | +$1.12M |
|
843
Dyne Therapeutics
DYN
$4.85B
| $32.1M | ﹤0.01% |
1,132,092
+1,118,590
| +8,285% | +$25.3M |
|
844
Stride
LRN
$3.48B
| $32.1M | ﹤0.01% |
508,444
+439,911
| +642% | +$26.5M |
|
845
Choice Hotels
CHH
$4.71B
| $32M | ﹤0.01% |
253,582
-95,768
| -27% | -$11.4M |
|
846
Braze
BRZE
$3.36B
| $32M | ﹤0.01% |
721,645
-405,753
| -36% | -$21.9M |
|
847
Guardant Health
GH
$21.4B
| $31.9M | ﹤0.01% |
1,545,114
-274,470
| -15% | -$5.88M |
|
848
Brown-Forman Class B
BF.B
$12.9B
| $31.8M | ﹤0.01% |
616,309
+58,164
| +10% | +$3.24M |
|
849
StoneX
SNEX
$8.05B
| $31.7M | ﹤0.01% |
1,521,349
+5,090
| +0.3% | +$102K |
|
850
Federal Realty Investment Trust
FRT
$10.3B
| $31.6M | ﹤0.01% |
309,103
+19,453
| +7% | +$1.97M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.